Pfiz­er to 'wind down con­struc­tion' of Seagen's $350M man­u­fac­tur­ing site

Pfiz­er is set to stop con­struc­tion of a man­u­fac­tur­ing fa­cil­i­ty start­ed by Seagen in Wash­ing­ton state, with af­fect­ed em­ploy­ees pos­si­bly mov­ing to oth­er fa­cil­i­ties, a spokesper­son con­firmed to End­points News.

“Af­ter care­ful eval­u­a­tion, we have made the dif­fi­cult de­ci­sion to wind down con­struc­tion of the site,” the spokesper­son said in an email. “There are ap­prox­i­mate­ly 120 em­ploy­ees who have been work­ing on the ini­tial set­up of the site that will be im­pact­ed.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER